Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT): a Multicenter, Observational Clinical Trial

NCT04985032 is registered in ClinicalTrials.gov with RPCR, Inc. as lead sponsor.

NCT NCT04985032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04985032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT): a Multicenter, Observational Clinical Trial
Lead sponsor
RPCR, Inc.
Phase
Observational
Overall status
Recruiting
Start date
August 15, 2022
Completion date
June 30, 2027
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ductal carcinoma in situ, invasive ductal carcinoma of female breast